Xortx Therapeutics Stock Analysis
| XRTX Stock | USD 1.01 0.04 3.81% |
XORTX Therapeutics is fairly valued with Real Value of 0.99 and Hype Value of 1.01. The main objective of XORTX Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what XORTX Therapeutics is worth, separate from its market price. There are two main types of XORTX Therapeutics' stock analysis: fundamental analysis and technical analysis.
The XORTX Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. XORTX Therapeutics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. XORTX Stock trading window is adjusted to America/New York timezone.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. XORTX Stock Analysis Notes
The company has Price to Book (P/B) ratio of 1.15. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. XORTX Therapeutics has Price/Earnings (P/E) ratio of 170.67. The entity recorded a loss per share of 1.15. The firm last dividend was issued on the January 31, 2014. XORTX Therapeutics had 1:9 split on the 14th of November 2023. XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. Xortx Therapeutics is traded on NASDAQ Exchange in the United States. For more information please call Allen Davidoff at 403-455-7727 or visit https://www.xortx.com.XORTX Therapeutics Investment Alerts
| XORTX Therapeutics had very high historical volatility over the last 90 days | |
| XORTX Therapeutics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (2.16 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| XORTX Therapeutics currently holds about 13.42 M in cash with (6.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
XORTX Therapeutics Upcoming and Recent Events
Earnings reports are used by XORTX Therapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
XORTX Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.83 M.Technical Drivers
As of the 4th of May, XORTX Therapeutics maintains the Mean Deviation of 4.28, downside deviation of 4.82, and Market Risk Adjusted Performance of 0.5241. In relation to fundamental indicators, the technical analysis model lets you check available technical drivers of XORTX Therapeutics, as well as the relationship between them.XORTX Therapeutics Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. XORTX Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for XORTX Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
XORTX Therapeutics Predictive Daily Indicators
XORTX Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of XORTX Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
XORTX Therapeutics Forecast Models
XORTX Therapeutics' time-series forecasting models are one of many XORTX Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary XORTX Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About XORTX Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how XORTX Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling XORTX shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as XORTX Therapeutics. By using and applying XORTX Stock analysis, traders can create a robust methodology for identifying XORTX entry and exit points for their positions.
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. Xortx Therapeutics is traded on NASDAQ Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding XORTX Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Additional Tools for XORTX Stock Analysis
When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.